NEW YORK, Feb. 21 (GenomeWeb News) - Carna Biosciences has acquired the exclusive worldwide rights to sell CrystalGenomics' kinase crystallization-related products and services, the companies said today.

Specific terms of the deal were not disclosed.

Carna, which is based in Japan, and CrystalGenomics, which is based on Korea, have been jointly researching kinase inhibitors since forming an alliance in June 2004.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.